Inter-laboratory Quality Assurance for Neonatal G6PD Screening
(Survey No: 92-07)


   Sample sent on : July 7, 2003   Report deadlineJuly 14, 2003

   Total screening unit11      Total reports returned11


Sample No.

A1

A2

A3

 B1 B2 C1 C2 C3 C4 C5 D1

G6PD activity*

1

0.3()

1.3()

0.1()

1.2()

0.6()

0.55(+)

0.2(+)

1.8(+)

2

1.8()

5.7()

2.1 (-)

1.8 (-)

1.7(+)

3.16 (-)

1.2 (-)

4.6

3

1.9(+)

6.4 (-)

1.7 (-)

1.9 (-)

1.9(+)

2.44 (-)

1.3 (-)

4.6

4

2.0(+)

6.3 (-)

1.6 (-)

2.5()

1.6()

3.07 (-)

1.4 (-)

4.6

5

0.4(+)

0.7(+)

0.1()

0.6(+)

0.5()

 0.67 ()

0.2(+)

1.8(+)

6

1.8(+)

5.4()

2.0 (-)

1.9 (-)

2.6(-)

3.37 (-)

1.4 (-)

4.6

7

1.8(+)

6.7 (-)

1.9 (-)

1.7 (-)

2.6(-)

3.18 (-)

1.3 (-)

4.6

8

0.4(+)

1.6()

0.1()

0.2(+)

0.7()

0.63(+)

0.2(+)

1.8(+)

9

1.9(+)

6.1(-)

1.7 (-)

1.7 (-)

1.7(+)

3.48 (-)

1.3 (-)

4.6

10

1.9(+)

6.1(-)

1.7(-)

2.4()

4.8()

2.13(-)

1.2(-)

4.6

                                 *  G6PDU/g Hb, determined at Clin. Biochem. Res. Lab, VGH-Taipei

                         ** The positive result assigned by the participants are indicated by red color in the table.

Reagent Kit

Screening Units

 Roche  A1, C2
 PE (ND-1000)  A2, B1, C1, D1
 Sigma Diagnostic 345B  A3
 Gamma (G6PD-2000)  C4
 R & D Diagnostics (OSMMR2000-D)  C5
 Laboratory prepared  B2, C3

Preventive Medicine Foundation
Address : P.O. Box 624 Taipei Xinwei, Taiwan, 10699
TEL : +886-2-2703-6080 ; Fax : +886-2-2703-6070
email :

updated : 20 Dec, 2004

[Home]


HOME